Medincell S.A [MEDCL] vs Valneva SE [VLA] Detailed Stock Comparison

Medincell S.A.

EURONEXT

Valneva SE

EURONEXT

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Medincell S.A. wins in 9 metrics, Valneva SE wins in 7 metrics, with 0 ties. Medincell S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Medincell S.A.	Valneva SE	Better
P/E Ratio (TTM)	-37.35	70.64	Valneva SE
Price-to-Book Ratio	N/A	3.91	N/A
Debt-to-Equity Ratio	-2.40	195.21	Valneva SE
PEG Ratio	96.66	8.67	Valneva SE
EV/EBITDA	-85.82	-7.93	Valneva SE
Profit Margin (TTM)	-61.49%	-65.95%	Medincell S.A.
Operating Margin (TTM)	-46.74%	-58.05%	Medincell S.A.
Return on Equity	112.65%	-80.16%	Medincell S.A.
Return on Assets (TTM)	-9.16%	-11.35%	Medincell S.A.
Free Cash Flow (TTM)	$17.81M	$-57.38M	Medincell S.A.
1-Year Return	23.51%	-12.60%	Medincell S.A.
Price-to-Sales Ratio (TTM)	26.03	2.38	Valneva SE
Enterprise Value	$821.18M	$512.93M	Medincell S.A.
EV/Revenue Ratio	25.31	2.94	Valneva SE
Gross Profit Margin (TTM)	N/A	24.36%	N/A
Revenue per Share (TTM)	$1	$1	Valneva SE
Earnings per Share (Diluted)	$-0.61	$-0.68	Medincell S.A.
Beta (Stock Volatility)	0.98	1.53	Medincell S.A.

Medincell S.A. vs Valneva SE Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Medincell S.A.	1.46%	-0.86%	1.61%	25.88%	25.88%	25.88%
Valneva SE	0.26%	-0.87%	-7.29%	-50.43%	-38.11%	-39.58%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Medincell S.A.	23.51%	23.51%	23.51%	23.51%	23.51%	23.51%
Valneva SE	-12.60%	-66.27%	-79.59%	0.44%	-55.71%	-55.71%

Performance & Financial Health Analysis: Medincell S.A. vs Valneva SE

Metric	MEDCL	VLA
Market Information
Market Cap i	€831.60M	€416.14M
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	92,952	1,269,682
90 Day Avg. Volume i	93,297	1,692,498
Last Close	€27.82	€2.29
52 Week Range	€15.00 - €39.68	€2.13 - €5.41
% from 52W High	-29.89%	-57.67%
All-Time High	€39.68 (Oct 31, 2025)	€29.70 (Nov 29, 2021)
% from All-Time High	-29.89%	-92.29%
Growth Metrics
Quarterly Revenue Growth	0.50%	-0.10%
Quarterly Earnings Growth	N/A	-0.10%
Financial Health
Profit Margin (TTM) i	-0.61%	-0.66%
Operating Margin (TTM) i	-0.47%	-0.58%
Return on Equity (TTM) i	1.13%	-0.80%
Debt to Equity (MRQ) i	-2.40	195.21
Cash & Liquidity
Book Value per Share (MRQ)	€-0.93	€0.61
Cash per Share (MRQ)	€1.62	€0.63
Operating Cash Flow (TTM) i	€-16,897,000	€-52,894,000
Levered Free Cash Flow (TTM) i	€-14,344,875	€-49,673,376
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Medincell S.A. vs Valneva SE

Metric	MEDCL (Apr 26, 2026)	VLA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i	-37.35	70.64
Forward P/E i	96.66	8.67
PEG Ratio i	96.66	8.67
Price to Sales (TTM) i	26.03	2.38
Price to Book (MRQ) i	N/A	3.91
Market Capitalization
Market Capitalization i	€831.60M	€416.14M
Enterprise Value i	€821.18M	€512.93M
Enterprise Value Metrics
Enterprise to Revenue i	25.31	2.94
Enterprise to EBITDA i	-85.82	-7.93
Risk & Other Metrics
Beta i	0.98	1.53
Book Value per Share (MRQ) i	€-0.93	€0.61

Financial Statements Comparison: Medincell S.A. vs Valneva SE

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric	MEDCL (2025)	VLA (2025)
Revenue/Sales i	25.54M	174.66M
Cost of Goods Sold i	0	107.14M
COGS % of Revenue i	0.0%	61.3%
Gross Profit i	25.54M	67.52M
Gross Margin i	100.0%	38.7%
Research & Development i	24.31M	85.30M
Operating Income (EBIT) i	-10.84M	-81.63M
Operating Margin i	-42.4%	-46.7%
EBITDA i	-11.20M	-57.24M
EBITDA Margin i	-43.9%	-32.8%
Pre-Tax Income i	-18.28M	-114.12M
Pre-Tax Income % of Revenue i	-71.6%	-65.3%
Income Tax i	160,000	1.07M
Income Tax % of Revenue i	0.6%	0.6%
Net Income (Profit) i	-18.44M	-115.19M
Profit Margin i	-72.2%	-66.0%

Balance Sheet & Liquidity Metrics

Metric	MEDCL (2025)	VLA (2025)
Cash & Equivalents i	59.04M	109.65M
Total Current Assets i	80.62M	222.54M
Total Current Assets % of Revenue i	315.6%	127.4%
Total Current Liabilities i	29.87M	93.33M
Total Current Liabilities % of Revenue i	117.0%	53.4%
Long-Term Debt i	51.46M	186.60M
Long-Term Debt % of Revenue i	201.5%	106.8%
Total Shareholders Equity i	-16.37M	106.17M
Retained Earnings i	-18.44M	-679.12M
Retained Earnings % of Revenue i	-72.2%	-388.8%
Property, Plant & Equipment i	7.80M	76.25M

Cash Flow Statement Comparison

Metric	MEDCL (2025)	VLA (2025)
Operating Cash Flow i	14.12M	-48.13M
Operating Cash Flow % of Revenue i	55.3%	-27.6%
Capital Expenditures i	-747,000	-4.29M
Free Cash Flow i	17.81M	-57.38M
FCF Margin i	69.7%	-32.8%
Debt Repayment i	-4.11M	-174.34M
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	MEDCL	VLA
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Shares Outstanding i	33.10M	173.42M
Float Shares i	30.23M	141.46M
% Held by Insiders i	35.05%	11.81%
% Held by Institutions i	30.34%	22.10%
% Held by Public i	34.61%	66.09%

Dividend Analysis & Yield Comparison: Medincell S.A. vs Valneva SE

Metric	MEDCL	VLA
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Medincell S.A [MEDCL] vs Valneva SE [VLA] Detailed Stock Comparison

Medincell S.A.

Valneva SE

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Medincell S.A. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Medincell S.A. vs Valneva SE Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Medincell S.A. vs Valneva SE

Valuation & Enterprise Metrics Analysis: Medincell S.A. vs Valneva SE

Financial Statements Comparison: Medincell S.A. vs Valneva SE

Financial Metrics

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

MEDCL (Annual)

MEDCL (Quarterly)

VLA (Annual)

VLA (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Medincell S.A. vs Valneva SE

Metric	MEDCL (Sep 30, 2018)	VLA (Dec 31, 2025)
Revenue/Sales i	N/A	47.69M
Cost of Goods Sold i	N/A	36.07M
COGS % of Revenue i	-	75.6%
Gross Profit i	N/A	11.62M
Gross Margin i	-	24.4%
Research & Development i	N/A	25.57M
Operating Income (EBIT) i	N/A	-27.69M
Operating Margin i	-	-58.1%
EBITDA i	N/A	-26.91M
EBITDA Margin i	-	-56.4%
Pre-Tax Income i	N/A	-51.08M
Pre-Tax Income % of Revenue i	-	-107.1%
Income Tax i	N/A	-1.06M
Income Tax % of Revenue i	-	-2.2%
Net Income (Profit) i	N/A	-50.02M
Profit Margin i	-	-104.9%

Metric	MEDCL (Sep 30, 2018)	VLA (Dec 31, 2025)
Cash & Equivalents i	49.77M	109.65M
Total Current Assets i	61.36M	222.54M
Total Current Assets % of Revenue i	-	466.7%
Total Current Liabilities i	21.33M	93.33M
Total Current Liabilities % of Revenue i	-	195.7%
Long-Term Debt i	52.64M	186.60M
Long-Term Debt % of Revenue i	-	391.3%
Total Shareholders Equity i	-30.63M	106.17M
Retained Earnings i	-16.08M	-679.12M
Retained Earnings % of Revenue i	-	-1,424.1%
Property, Plant & Equipment i	7.80M	76.25M

Metric	MEDCL (Sep 30, 2018)	VLA (Dec 31, 2025)
Operating Cash Flow i	N/A	-61.08M
Operating Cash Flow % of Revenue i	-	-128.1%
Capital Expenditures i	N/A	-1.04M
Free Cash Flow i	N/A	-25.59M
FCF Margin i	-	-53.7%
Debt Repayment i	N/A	-170.88M
Common Stock Repurchase i	N/A	N/A

Medincell S.A [MEDCL] vs Valneva SE [VLA] Detailed Stock Comparison

Medincell S.A.

Valneva SE

TLDR: Quick Comparison Summary

Vital Metrics Comparison

Complete Medincell S.A. Investment Analysis: Compare with Industry Leaders

Ever Wonder Which Stock is Really the Better Pick?

What You'll Actually Learn (in Plain English)

💰 Which Stock is Cheaper

🏥 Which Company is Healthier

📈 Which Has Been Growing Faster

💵 Which Pays You Better

Medincell S.A. vs Valneva SE Stock Performance Analysis

Performance Comparison

Short-term Returns

Long-term Returns

Performance & Financial Health Analysis: Medincell S.A. vs Valneva SE

Valuation & Enterprise Metrics Analysis: Medincell S.A. vs Valneva SE

Financial Statements Comparison: Medincell S.A. vs Valneva SE

Financial Metrics Quarterly Annual

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

MEDCL (Annual)

MEDCL (Quarterly)

VLA (Annual)

VLA (Quarterly)

Financial Statements Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Income Statement

Balance Sheet & Liquidity Metrics

Cash Flow Statement Comparison

Short Interest & Institutional Ownership Analysis

Dividend Analysis & Yield Comparison: Medincell S.A. vs Valneva SE

Financial Metrics